Ledger.Open graph →
SEC Form D · filed November 3, 2023

Centerline Biomedical, Inc

Offering
$34.7M
Sold
$34.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Vinod K. Goel · Cleveland, OHExecJonathan P. Michael · Menlo Park, CADirectorChristopher Mclaughlin · Chicago, ILDirectorPhil N. Rackliffe · Cleveland, OHExec · DirectorAkhil Saklecha · Cleveland, OHDirectorVikash K. Goel · Cleveland, OHExecYaron C. Ashkenazi · Scottsdale, AZExec · DirectorJames R. Mccaffrey · Alpharetta, GAExecVinod K. Goel · Cleveland, OHExecGulam Khan · Cleveland, OHExecGulam Khan · Cleveland, OHExecVikash K. Goel · Cleveland, OHExecPhil N. Rackliffe · Cleveland, OHExec · DirectorMitch Wolf · Cleveland, OHDirectorMitch Wolf · Cleveland, OHDirectorEdward C. Copelin · Alpharetta, GAExecJacob Claver · CANTON, TXExecTodd Schwarzinger · Cleveland, OHDirectorTodd Schwarzinger · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗